SEB Sverige Indexnära A vs UBS Lux Equity Fund Biotech USD

SEB Sverige Indexnära A vs UBS Lux Equity Fund Biotech USD

1. SEB Sverige Indexnära A

  • Security

    SEB Sverige Indexnära A

  • Fee

    0.25%

  • ISIN

    SE0002593673

  • Holdings

    25

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 35 holdings in SEB Sverige Indexnära A, where the largest holding is Investor (8.54), followed by Atlas Copco (7.82) and Volvo (5.9). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in SEB Sverige Indexnära A and UBS Lux Equity Fund Biotech USD.

SEB Sverige Indexnära A UBS Lux Equity Fund Biotech USD
1. Investor B
Sweden
8.54 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Atlas Copco A
Sweden
7.82 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Volvo B
Sweden
5.9 %
3. Moderna Inc
9.21 %
4. EQT AB
Sweden
3.6 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. SEB A
Sweden
3.15 %
5. AbbVie Inc
USA
5.52 %
6. Assa Abloy B
Sweden
3.02 %
6. Gilead Sciences Inc
USA
4.66 %
7. Hexagon B
Sweden
2.76 %
7. Amgen Inc
4.32 %
8. Ericsson B
Sweden
2.57 %
8. BioNTech SE
4.13 %
9. Swedbank A
Sweden
2.55 %
9. Karuna Therapeutics Inc
3.75 %
10. Sandvik
Sweden
2.54 %
10. Royalty Pharma Plc
3.28 %
11. Handelsbanken A
Sweden
2.33 %
-
12. Epiroc A
Sweden
2.22 %
-
13. ABB Ltd
Sweden Switzerland
2.19 %
-
14. AstraZeneca
Sweden UK
2.17 %
-
15. Essity B
Sweden
1.82 %
-
16. Hennes & Mauritz B
Sweden
1.77 %
-
17. Alfa Laval
Sweden
1.68 %
-
18. Industrivärden A
Sweden
1.53 %
-
19. Latour B
Sweden
1.5 %
-
20. Lifco B
Sweden
1.36 %
-
21. Telia Company
Sweden
1.2 %
-
22. Indutrade AB
Sweden
0.98 %
-
23. Swedish Orphan Biovitrum AB
Sweden
0.98 %
-
24. SKF B
Sweden
0.92 %
-
25. SCA B
Sweden
0.9 %
-

The list of fund holdings was last updated on April 17, 2025.